Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

The β-herpesvirus human herpesvirus-6 (HHV-6) is becoming increasingly recognized as an important pathogen in immunocompromised patients, particularly in post bone marrow transplant (BMT). Reactivation of latent HHV-6 resulting in encephalitis has been reported in BMT and stem cell transplant (SCT) patients. The development of HHV-6 encephalitis can be a fatal complication, the frequency of which is increasing likely due to improved diagnosis with quantitative polymerase chain reaction (PCR) of cerebrospinal fluid. There are currently no antiviral compounds approved for HHV-6, nor have any controlled clinical trials been conducted. The frequency and severity of HHV-6 encephalitis in both immunocompetent and immunocompromised patients necessitates studies on the usefulness of currently available anti-viral compounds. The authors compared the antiviral efficacy of four drugs currently used for cytomegalovirus (CMV) infection, a β-herpesvirus sharing homology with HHV-6. In HHV-6A— and HHV-6B—infected T cells, acyclovir, ganciclovir, foscarnet, and cidofovir exhibited antiviral activity consistent with that published in other studies. In HHV-6-infected human astrocytes (U251), however, only foscarnet and cidofovir exhibited antiviral activity and this effect was restricted to infection with HHV-6 variant A. In pathological brain sections from patients with neurological disorders such as multiple sclerosis and epilepsy, HHV-6 has been localized to glial cells. Determination of antiviral activity in human glial fibrillary acidic protein (GFAP)-positive astrocytes of currently used antiviral compounds is essential for potential treatment of HHV-6 and neurological disorders. Our data highlight the necessity for further study of antiviral compound in HHV-6—infected glial cells as well as the development of more selective compounds for HHV-6.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ablashi DV, Salahuddin SZ, Josephs SF, Imam F, Lusso P, Gallo RC, Hung C, Lemp J, Markham PD (1987). HBLV (or HHV-6) in human cell lines. Nature 329: 207.

    Article  CAS  PubMed  Google Scholar 

  • Ahlqvist J, Fotheringham J, Akhyani N, Yao K, Fogdell-Hahn A, Jacobson S (2005). Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J NeuroVirol 11: 384–394.

    Article  CAS  PubMed  Google Scholar 

  • Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, Jacobson S (2000). Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 182: 1321–1325.

    Article  CAS  PubMed  Google Scholar 

  • Bethge W, Beck R, Jahn G, Mundinger P, Kanz L, Einsele H (1999). Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 24: 1245–1248.

    Article  CAS  PubMed  Google Scholar 

  • Birnbaum T, Padovan CS, Sporer B, Rupprecht TA, Ausserer H, Jaeger G, Pfister HW (2005). Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir. Clin Infect Dis 40: 887–889.

    Article  PubMed  Google Scholar 

  • Burns WH, Sandford GR (1990). Susceptibility of human herpesvirus 6 to antivirals in vitro. J Infect Dis 162: 634–637.

    CAS  PubMed  Google Scholar 

  • Campadelli-Fiume G, Mirandola P, Menotti L (1999). Human herpesvirus 6: an emerging pathogen. Emerg Infect Dis 5: 353–566.

    Article  CAS  PubMed  Google Scholar 

  • Caserta MT, Hall CB, Schnabel K, McIntyre K, Long C, Costanzo M, Dewhurst S, Insel R, Epstein LG (1994). Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 170: 1586–1589.

    CAS  PubMed  Google Scholar 

  • Cermelli C, Berti R, Soldan SS, Mayne M, D’Ambrosia JM, Ludwin SK, Jacobson S (2003). High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 187: 1377–1387.

    Article  CAS  PubMed  Google Scholar 

  • Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, et al (1995). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92: 7440–7444.

    Article  CAS  PubMed  Google Scholar 

  • Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, Caruso R, Calogero A, Frati L, Faggioni A, Ragona G (2001). Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 63: 45–51.

    Article  CAS  PubMed  Google Scholar 

  • De Bolle L, Andrei G, Snoeck R, Zhang Y, Van Lommel A, Otto M, Bousseau A, Roy C, De Clercq E, Naesens L (2004). Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. Biochem Pharmacol 67: 325–336.

    Article  PubMed  Google Scholar 

  • De Bolle L, Naesens L, De Clercq E (2005a). Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18: 217–245.

    Article  PubMed  Google Scholar 

  • De Bolle L, Van Loon J, De Clercq E, Naesens L (2005b). Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 75: 76–85.

    Article  PubMed  Google Scholar 

  • De Clercq E (2005). Antiviral drug discovery and development: where chemistry meets with biomedicine. Antiviral Res 67: 56–75.

    Article  PubMed  Google Scholar 

  • Denes E, Magy L, Pradeau K, Alain S, Weinbreck P, Ranger-Rogez S (2004). Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient. Emerg Infect Dis 10: 729–731.

    PubMed  Google Scholar 

  • Dewhurst S (2004). Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 11(Suppl 2): 105A-111A.

    PubMed  Google Scholar 

  • Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, Heiss JD, Cogen P, Gaillard WD, Sato S, Theodore WH, Jacobson S (2003). Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61: 1405–1411.

    CAS  PubMed  Google Scholar 

  • Donati D, Martinelli E, Cassiani-Ingoni R, Ahlqvist J, Hou J, Major EO, Jacobson S (2005). Variant-specific tropism of human herpesvirus 6 in human astrocytes. J Virol 79: 9439–9448.

    Article  CAS  PubMed  Google Scholar 

  • Flebbe-Rehwaldt LM, Wood C, Chandran B (2000). Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames. J Virol 74: 11040–11054.

    Article  CAS  PubMed  Google Scholar 

  • Ghedin E, Pumfery A, de la Fuente C, Yao K, Miller N, Lacoste V, Quackenbush J, Jacobson S, Kashanchi F (2004). Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis. Retrovirology 1: 10.

    Article  PubMed  Google Scholar 

  • He J, McCarthy M, Zhou Y, Chandran B, Wood C (1996). Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 70: 1296–1300.

    CAS  PubMed  Google Scholar 

  • Hengge UR, Brockmeyer NH, Malessa R, Ravens U, Goos M (1993). Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis. Antimicrob Agents Chemother 37: 1010–1014.

    CAS  PubMed  Google Scholar 

  • Isaacson E, Glaser CA, Forghani B, Amad Z, Wallace M, Armstrong RW, Exner MM, Schmid S (2005). Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 40: 890–893.

    Article  PubMed  Google Scholar 

  • Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y, Sunagawa T, Kawanishi K, Sashihara J, Hata A, Zou P, Kosuge H, Yamanishi K (1999). Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 73: 8053–8063.

    CAS  PubMed  Google Scholar 

  • Janelle ME, Flamand L (2006). Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6. Arch Virol 51: 1603–1614.

    Article  Google Scholar 

  • Kimberlin DW, Whitley RJ (1998). Human herpesvirus-6: neurologic implications of a newly-described viral pathogen. J NeuroVirol 4: 474–485.

    Article  CAS  PubMed  Google Scholar 

  • Knox KK, Harrington DP, Carrigan DR (1995). Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 45: 288–292.

    Article  CAS  PubMed  Google Scholar 

  • Maeda Y, Teshima T, Yamada M, Harada M (2000). Reactivation of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Leuk Lymphoma 39: 229–239.

    Article  CAS  PubMed  Google Scholar 

  • Manichanh C, Grenot P, Gautheret-Dejean A, Debre P, Huraux JM, Agut H (2000). Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry 40: 135–140.

    Article  CAS  PubMed  Google Scholar 

  • Maschke M, Kastrup O, Diener HC (2002). CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs 16: 303–315.

    Article  CAS  PubMed  Google Scholar 

  • Matthews T, Boehme R (1988). Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 10(Suppl 3): S490-S494.

    CAS  PubMed  Google Scholar 

  • Mirandola P, Menegazzi P, Merighi S, Ravaioli T, Cassai E, Di Luca D (1998). Temporal mapping of transcripts in herpesvirus 6 variants. J Virol 72: 3837–3844.

    CAS  PubMed  Google Scholar 

  • Mookerjee BP, Vogelsang G (1997). Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 20: 905–906.

    Article  CAS  PubMed  Google Scholar 

  • Niiya H, Azuma T, Jin L, Uchida N, Inoue A, Hasegawa H, Fujita S, Tohyama M, Hashimoto K, Yasukawa M (2004). Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells. J Gen Virol 85: 2639–2642.

    Article  CAS  PubMed  Google Scholar 

  • Nitsche A, Muller CW, Radonic A, Landt O, Ellerbrok H, Pauli G, Siegert W (2001). Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 183: 130–133.

    Article  CAS  PubMed  Google Scholar 

  • Opsahl ML, Kennedy PG (2005). Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 128: 516–527.

    Article  PubMed  Google Scholar 

  • Opsahl ML, Kennedy PG (2006). Investigating the presence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue. J Neurol Sci 240: 37–44.

    Article  CAS  PubMed  Google Scholar 

  • Oster B, Hollsberg P (2002). Viral gene expression patterns in human herpesvirus 6B-infected T cells. J Virol 76: 7578–7586.

    Article  CAS  PubMed  Google Scholar 

  • Rapaport D, Engelhard D, Tagger G, Or R, Frenkel N (2002). Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transplant Infect Dis 4: 10–16.

    Article  CAS  Google Scholar 

  • Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H, De Clercq E (1995). Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 28: 343–357.

    Article  CAS  PubMed  Google Scholar 

  • Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al (1986). Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596–601.

    Article  CAS  PubMed  Google Scholar 

  • Schneider U, Schwemmle M, Staeheli P (2005). Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc Natl Acad Sci U S A 102: 3441–3446.

    Article  CAS  PubMed  Google Scholar 

  • Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S (1997). Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3: 1394–1397.

    Article  CAS  PubMed  Google Scholar 

  • Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T (1988). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065–1067.

    Article  CAS  PubMed  Google Scholar 

  • Yao K, Mandel M, Akyani N, Maynard K, Sengamalay N, Fotheringham J, Ghedin E, Kashanchi F, Jacobson S (2006). Differential HHV-6A gene expression in T cells and primary human astrocytes based on multi-virus array analysis. Glia 53: 789–798.

    Article  PubMed  Google Scholar 

  • Yoshida H, Matsunaga K, Ueda T, Yasumi M, Ishikawa J, Tomiyama Y, Matsuzawa Y (2002). Human herpesvirus 6 meningoencephalitis successfully treated with ganciclovir in a patient who underwent allogeneic bone marrow transplantation from an HLA-identical sibling. Int J Hematol 75: 421–425.

    Article  PubMed  Google Scholar 

  • Yoshikawa T, Asano Y, Akimoto S, Ozaki T, Iwasaki T, Kurata T, Goshima F, Nishiyama Y (2002). Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol 66: 497–505.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Viral Immunology Section, NINDS/NIH, 10 Center Drive, Building 10 Room 5B16, 20892, Bethesda, MD, USA

    Nahid Akhyani, Julie Fotheringham, Karen Yao, Farzin Rashti & Steven Jacobson

  2. Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA

    Karen Yao

  3. Howard University College of Medicine, Washington, DC, USA

    Farzin Rashti

Authors
  1. Nahid Akhyani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Fotheringham
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karen Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Farzin Rashti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Steven Jacobson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven Jacobson.

Additional information

J.F. is supported by the Canadian Multiple Sclerosis Society.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akhyani, N., Fotheringham, J., Yao, K. et al. Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells. Journal of NeuroVirology 12, 284–293 (2006). https://doi.org/10.1080/13550280600880772

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280600880772

Keywords

Search

Navigation